A new, revolutionary bloodless treatment

For prostate cancer

This pioneering treatment for localised, low-grade prostate cancer uses the most advanced diagnostic techniques, such as multiparametric prostate MRI and prostate fusion biopsy, to accurately locate cancerous tissue. Subsequently, irreversible electroporation is performed on the cancer cells through three to four needles placed percutaneously through the perineum using special coordinates.

Electrical currents are applied through them, causing necrosis of the cancer cells and destroying them without affecting the surrounding healthy tissues or increasing the temperature, as the energy source automatically maintains normal temperature levels. This method offers a safe and effective alternative, avoiding the side effects of traditional treatments, such as radical prostatectomy or radiotherapy, which often cause significant complications, such as erectile dysfunction and incontinence, loss of ejaculation, bowel disorders.

The procedure takes about an hour and entails a rapid recovery, enabling patients to resume their daily activities almost immediately. It involves a one-day hospital stay and a short recovery period.

 
What are the advantages of this method?
  • A bloodless, minimally invasive approach: No open surgery or incisions are required to insert the robotic-laparoscopic tools, which minimises recovery time and the risk of complications.
  • Maintaining erectile function and ejaculation: Unlike other meth-
    ods, this technique preserves the full function of the genitourinary system.
  • No damage to nerves or blood vessels: Electroporation targets cancer cells exclusively, leaving healthy tissue intact.
  • Fast recovery and minimal side effects: Most patients can resume their normal daily activities within 24-48 hours.
  • High efficacy: This technique has been shown to be highly effective in eliminating cancer cells, providing an alternative to the traditional radical prostatectomy.
 
Which patients is the method suitable for?

This treatment is intended for men with localised, low-grade prostate cancer who are seeking a less aggressive approach. Patients who meet the selection criteria can avoid the effects of radiation or invasive procedures and maintain a high quality of life after treatment. Treatment options are always decided in collaboration with the treating physician after a detailed evaluation of each patient’s case.

Published in the magazine Libro Di Levante

Θέλεις να μάθεις περισσότερα σχετικά με κάποια πάθηση;

Επικοινώνησε μαζί μου

Διαβάστε επίσης